CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Conversion | +548,755 | 548,755 | ||
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Purchase | +215,000 | $15.00 | $3.2M | 763,755 |
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Conversion · Series C Convertible Preferred Stock | −2,858,086 | 0 | ||
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Conversion | +548,755 | 548,755 | ||
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Purchase | +215,000 | $15.00 | $3.2M | 763,755 |
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Conversion · Series C Convertible Preferred Stock | −2,858,086 | 0 | ||
| 2017-07-20 | CDK ASSOCIATES, L.L.C. 10% owner | Purchase | +215,000 | $15.00 | $3.2M | 215,000 |
Page 1 of 1 · 7 trades